Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
暂无分享,去创建一个
[1] J. Calixto,et al. Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus. , 2005, Planta medica.
[2] J. McHowat,et al. Phospholipase A2 inhibitors as potential anti-inflammatory agents. , 2005, Current pharmaceutical design.
[3] J. Young,et al. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents , 1989, Agents and Actions.
[4] P. Bessin,et al. Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes , 1981, Agents and Actions.
[5] N. Morioka,et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice , 2004, Pain.
[6] J. Calixto,et al. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. , 2003, European journal of pharmacology.
[7] R. Kuttan,et al. Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. , 2003, Journal of ethnopharmacology.
[8] A. Vollmar,et al. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. , 2003, Journal of hepatology.
[9] S. C. Hess,et al. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. , 2002, European journal of pharmacology.
[10] R. Yunes,et al. Antinociceptive properties of extracts of new species of plants of the genus Phyllanthus (Euphorbiaceae). , 2000, Journal of ethnopharmacology.
[11] M. Wilson,et al. Platelet-activating factor and bacteremia-induced pulmonary hypertension. , 2000, The Journal of surgical research.
[12] S. Ishii,et al. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. , 2000, Progress in lipid research.
[13] K. Ahn,et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. , 1999, Biological & pharmaceutical bulletin.
[14] R. Yunes,et al. A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential , 1998, Medicinal research reviews.
[15] I. Lee,et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. , 1998, Journal of natural products.
[16] M. Webb,et al. A novel class of non-peptidic endothelin antagonists isolated from the medicinal herb Phyllanthus niruri , 1995 .
[17] M. Martins,et al. Yangambin: A New Naturally-Occurring Platelet-Activating Factor Receptor Antagonist: Binding and In Vitro Functional Studies , 1995, Planta medica.
[18] G. Webster,et al. Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. , 1995, Journal of ethnopharmacology.
[19] H. Bito,et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. , 1991, The Journal of biological chemistry.
[20] O. Gottlieb. The rational search for natural neolignans. , 1991, Memorias do Instituto Oswaldo Cruz.
[21] P. Braquet,et al. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. , 1990, The Journal of biological chemistry.
[22] M. Martins,et al. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse , 1990, British journal of pharmacology.
[23] P. Braquet,et al. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions. , 1987, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[24] X. Wang,et al. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor. , 1985, International journal of tissue reactions.
[25] G. Towers,et al. Biological activities of lignans , 1984 .
[26] E. J. Ariëns,et al. Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. Part II. Binding of (plus)-benzetimide, (minus)-benzetimide and atropine to a fraction from bovine tracheal smooth muscle and to bovine caudate nucleus. , 1974, European journal of pharmacology.
[27] W. Spector. The mediation of altered capillary permeability in acute inflammation , 1956 .